03:47 PM EST - Medicago Inc. : announces that its Medicago USA Inc., has received the second milestone payment of $3.8 million U.S. from the Defense Advanced Research Projects Agency ("DARPA"). This is part of the $21-million U.S. DARPA grant awarded to Medicago to demonstrate the scalable manufacturing of its plant-expressed VLP vaccines in the U.S.A. under a Technology Investment Agreement. Medicago has received $10.7 million U.S. to date for this project. Medicago Inc.
shares T.MDG are trading down $0.005 at $0.47.
